Mesenchymal stem cells (MSCs) are multi-potent adult stem cells harboring multi-lineage
differentiation potential and immunosuppressive properties that make MSCs an ideal …

Mesenchymal stem cells (MSCs) have been used in cell‐based therapy in various disease
conditions such as graft‐versus‐host and heart diseases, osteogenesis imperfecta, and …

Stem cells transplanted to the ischemic myocardium usually encounter massive cell death
within a few days of therapy. Hypoxic preconditioning (HPC) is currently employed as a …

There is currently much interest in adult mesenchymal stem cells (MSCs) and their ability to
differentiate into other cell types, and to partake in the anatomy and physiology of remote …

Mesenchymal stem cells (MSCs) hold many advantages over embryonic stem cells (ESCs)
and other somatic cells in clinical applications. MSCs are multipotent cells with strong …

Despite refinements of medical and surgical therapies, heart failure remains a fatal disease.
Myocardial infarction is the most common cause of heart failure, and only palliative …

Background aims The immunomodulating capacity of multipotent mesenchymal stromal
cells (MSCs) qualifies them as a therapeutic tool in several diseases. However, repeated …

The effects of cryopreservation on mesenchymal stem cell (MSC) phenotype are not well
documented; however this process is of increasing importance for regenerative therapies …

Background Heart failure (HF) is the end stage of most heart disease. Mesenchymal stem
cells (MSCs), with their specific biological effects, have been applied in several clinical trials …

Abstract Background Mesenchymal stem cells (MSCs) driven gene directed enzyme prodrug
therapy is a promising approach to deliver therapeutic agents to target heterogenous solid …